183 related articles for article (PubMed ID: 38025711)
1. Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation.
Wu X; Zhou F; Cheng B; Tong G; Chen M; He L; Li Z; Yu S; Wang S; Lin L
PeerJ; 2023; 11():e16317. PubMed ID: 38025711
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
[TBL] [Abstract][Full Text] [Related]
4. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
5. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
6. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
7. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
[TBL] [Abstract][Full Text] [Related]
8. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer.
Qing X; Xu W; Liu S; Chen Z; Ye C; Zhang Y
Front Immunol; 2022; 13():843077. PubMed ID: 35273618
[TBL] [Abstract][Full Text] [Related]
10. Development and verification of an immune-related gene prognostic index for gastric cancer.
Zhang C; Liu T; Wang J; Zhang J
Sci Rep; 2022 Sep; 12(1):15693. PubMed ID: 36127384
[TBL] [Abstract][Full Text] [Related]
11. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
13. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
Front Immunol; 2022; 13():951135. PubMed ID: 36483555
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response.
Chen Y; Sun Z; Wan L; Chen H; Xi T; Jiang Y
Front Immunol; 2022; 13():890922. PubMed ID: 35572498
[TBL] [Abstract][Full Text] [Related]
15. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
16. Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract][Full Text] [Related]
17. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
[TBL] [Abstract][Full Text] [Related]
18. Identification of a lipid homeostasis-related gene signature for predicting prognosis, immunity, and chemotherapeutic effect in patients with gastric cancer.
Li C; Xiong Z; Han J; Nian W; Wang Z; Cai K; Gao J; Wang G; Tao K; Cai M
Sci Rep; 2024 Feb; 14(1):2895. PubMed ID: 38316848
[TBL] [Abstract][Full Text] [Related]
19. The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
Hong Z; Wen P; Wang K; Wei X; Xie W; Rao S; Chen X; Hou J; Zhuo H
BMC Cancer; 2024 Jan; 24(1):141. PubMed ID: 38287304
[TBL] [Abstract][Full Text] [Related]
20. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
[Next] [New Search]